The
The company attributed the increase to growth in its global medical cannabis business and quarterly revenue in its plant propagation business.
CEO
He says Aurora is experiencing the benefits of diversification across its cannabis and non-cannabis platforms.
The company's net revenue from medical cannabis rose 42 per cent from a year earlier, while revenues from consumer cannabis were slightly lower.
This report by The Canadian Press was first published
Companies in this story: (TSX:ACB)
© 2023 The Canadian Press. All rights reserved., source